115 related articles for article (PubMed ID: 3611952)
21. Elevation of serum chemotactic factor inactivator activity in rabbits induced by inflammation and chemotactic factor.
Hupp JR; Despins AW; McCormick JR; Armstrong G; Kreutzer DL
Am J Pathol; 1982 Dec; 109(3):277-82. PubMed ID: 7180941
[TBL] [Abstract][Full Text] [Related]
22. Attachment of human C5a des Arg to its cochemotaxin is required for maximum expression of chemotactic activity.
Perez HD; Chenoweth DE; Goldstein IM
J Clin Invest; 1986 Dec; 78(6):1589-95. PubMed ID: 3782473
[TBL] [Abstract][Full Text] [Related]
23. Neutrophil dysfunction in sepsis. II. Evidence for the role of complement activation products in cellular deactivation.
Solomkin JS; Jenkins MK; Nelson RD; Chenoweth D; Simmons RL
Surgery; 1981 Aug; 90(2):319-27. PubMed ID: 7256544
[TBL] [Abstract][Full Text] [Related]
24. Detection of a complement-derived chemotactic factor for tumor cells in human inflammatory and neoplastic effusions.
Orr FW; Delikatny EJ; Mokashi S; Krepart GV; Stiver HG
Am J Pathol; 1983 Jan; 110(1):41-7. PubMed ID: 6185003
[TBL] [Abstract][Full Text] [Related]
25. A specific inhibitor of complement (C5)-derived chemotactic activity in serum from patients with systemic lupus erythematosus.
Perez HD; Lipton M; Goldstein IM
J Clin Invest; 1978 Jul; 62(1):29-38. PubMed ID: 659635
[TBL] [Abstract][Full Text] [Related]
26. Human C5a and C5a des Arg exhibit chemotactic activity for fibroblasts.
Senior RM; Griffin GL; Perez HD; Webster RO
J Immunol; 1988 Nov; 141(10):3570-4. PubMed ID: 3183381
[TBL] [Abstract][Full Text] [Related]
27. Demonstration of C5 cleaving activity in bronchoalveolar fluids and cells: a mechanism of acute and chronic alveolitis.
Desai U; Dickey B; Varani J; Kreutzer DL
J Exp Pathol; 1984; 1(3):201-16. PubMed ID: 6400640
[TBL] [Abstract][Full Text] [Related]
28. Presence of chemotactic peptides other than C5a anaphylatoxin in scales of psoriasis and sterile pustular dermatoses.
Takematsu H; Terui T; Ohkohchi K; Tagami H; Suzuki R; Kumagai K
Acta Derm Venereol; 1986; 66(2):93-7. PubMed ID: 2424251
[TBL] [Abstract][Full Text] [Related]
29. Suppression of immune complex-induced inflammation by the chemotactic factor inactivator.
Johnson KJ; Anderson TP; Ward PA
J Clin Invest; 1977 May; 59(5):951-8. PubMed ID: 140184
[TBL] [Abstract][Full Text] [Related]
30. Quantification of C5a/C5a(desArg) in bovine plasma, serum and milk.
Rainard P; Sarradin P; Paape MJ; Poutrel B
Vet Res; 1998; 29(1):73-88. PubMed ID: 9559522
[TBL] [Abstract][Full Text] [Related]
31. Serum inhibitor of C5 fragment-mediated polymorphonuclear leukocyte chemotaxis associated with chronic hemodialysis.
Goldblum SE; Van Epps DE; Reed WP
J Clin Invest; 1979 Jul; 64(1):255-64. PubMed ID: 447856
[TBL] [Abstract][Full Text] [Related]
32. Activation of the complement system in the adult respiratory distress syndrome.
Robbins RA; Russ WD; Rasmussen JK; Clayton MM
Am Rev Respir Dis; 1987 Mar; 135(3):651-8. PubMed ID: 3826891
[TBL] [Abstract][Full Text] [Related]
33. Characterization of the protease activity in the chemotactic factor inactivator.
Ward PA; Ozols J
J Clin Invest; 1976 Jul; 58(1):123-9. PubMed ID: 6489
[TBL] [Abstract][Full Text] [Related]
34. Human monocyte adherence: a primary effect of chemotactic factors on the monocyte to stimulate adherence to human endothelium.
Doherty DE; Haslett C; Tonnesen MG; Henson PM
J Immunol; 1987 Mar; 138(6):1762-71. PubMed ID: 3819394
[TBL] [Abstract][Full Text] [Related]
35. Elevation of serum chemotactic factor inactivator activity during acute inflammatory reactions in patients with hypersensitivity pneumonitis.
Kreutzer DL; McCormick JR; Thrall RS; Hupp JR; Moore VL; Fink JN
Am Rev Respir Dis; 1982 May; 125(5):612-4. PubMed ID: 7081823
[TBL] [Abstract][Full Text] [Related]
36. Gcglobulin functions as a cochemotaxin in the lower respiratory tract. A potential mechanism for lung neutrophil recruitment in cigarette smokers.
Metcalf JP; Thompson AB; Gossman GL; Nelson KJ; Koyama S; Rennard SI; Robbins RA
Am Rev Respir Dis; 1991 Apr; 143(4 Pt 1):844-9. PubMed ID: 2008995
[TBL] [Abstract][Full Text] [Related]
37. Bovine milk fat globules do not inhibit C5a chemotactic activity.
Rainard P
Vet Res; 2002; 33(4):413-9. PubMed ID: 12199368
[TBL] [Abstract][Full Text] [Related]
38. Cessation of neutrophil influx in C5a-induced acute experimental arthritis is associated with loss of chemoattractant activity from the joint space.
Haslett C; Jose PJ; Giclas PC; Williams TJ; Henson PM
J Immunol; 1989 May; 142(10):3510-7. PubMed ID: 2715634
[TBL] [Abstract][Full Text] [Related]
39. Relationship between the C5 peptides chemotactic for leukocytes and tumor cells.
Romualdez AG; Ward PA; Torikata T
J Immunol; 1976 Nov; 117(5 Pt.2):1762-6. PubMed ID: 62790
[TBL] [Abstract][Full Text] [Related]
40. Selective inhibition by phenytoin of chemotactic factor - stimulated neutrophil functions.
Webster RO; Goldstein IM; Flick MR
J Lab Clin Med; 1984 Jan; 103(1):22-33. PubMed ID: 6317777
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
